Health

U.S. biotechnology company Moderna's shares gained more than 30 percent pre-market after the company said the vaccine for new coronary pneumonia, RNA-1273, is safe and well-tolerated and is expected to begin final stage vaccine trials in July.

A Chinese team recently published a paper online in the journal Science saying that they have identified two human monoclonal antibodies that can effectively block novel coronavirus infections, which could be used in the development of anti-neo-crown drugs and vaccines.

Many people know that diabetes is a group of metabolic diseases characterized by hyperglycemia, which is caused by a defect in insulin secretion or impaired biological action, or both.

Several countries around the world are focusing on the development of a new coronavirus vaccine, which is the key to stopping the virus pandemic in the future. The vaccine is not yet complete, but China Electronics Corporation has announced the completion of the world's largest new coronavirus vaccine manufacturing plant, with an annual production capacity of up to 100 million doses.

Recently, a study published in the European Heart Journal showed that men have higher levels of an important enzyme in their blood than women, which is used by novel coronaviruses to infect cells, which may help explain why men are more susceptible to COVID-19.

A multi-country study from Canada shows that temperature and latitude do not appear to be associated with the spread of the novel coronavirus (COVID-19), but school closures and other public health measures are having a positive impact.

At present, there are a lot of anti-blue light glasses on the market, and mobile phones also have anti-blue light mode, is this effective in protecting eyesight and preventing myopia?

The results of a recent trial from the University of Hong Kong showed that triple antiviral therapy with interferon β1b + ribavirin + lopinavir/ritonavir may accelerate recovery in mild to moderate patients.

Because of the novel coronavirus pneumonia epidemic, attention to the epidemic has intensified.

A new study of novel coronavirus-neutralizing antibodies led by Gao Fu, director of the Chinese Center for Disease Control and Prevention and a member of the Chinese Academy of Sciences, and other scholars shows that B38 and H4 antibodies block the binding of the novel coronavirus S protein receptor binding region RBD to the human cell receptor ACE2.